@article{fdi:010074944,
  title = {{E}ffect of the {B}olsa {F}amilia {P}rogramme on the outcome of tuberculosis treatment : a prospective cohort study},
  author = {{O}liosi, {J}. {G}. {N}. and {R}eis-{S}antos, {B}. and {L}ocatelli, {R}. {L}. and {S}ales, {C}. {M}. {M}. and {F}ilho, {W}. {G}. {D}. and da {S}ilva, {K}. {C}. and {S}anchez, {M}. {N}. and {A}ndrade, {K}. {V}. {F}. and {S}hete, {P}. {B}. and {P}ereira, {S}. {M}. and {R}iley, {L}. {W}. and {L}ienhardt, {C}hristian and {M}aciel, {E}. {L}. {N}. and {D}e {A}raojo, {G}. {S}.},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground {S}ocial protection interventions might improve tuberculosis outcomes and could help to control the epidemic in {B}razil. {T}he aim of this study was to evaluate the independent effect of the {B}olsa {F}amilia {P}rogramme ({BFP}) on tuberculosis treatment outcomes in {B}razil. {M}ethods {W}e prospectively recruited and followed up individuals (aged >= 18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in {B}razil, between {M}arch 1, 2014, and {A}pril 30, 2017. {P}atients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. {P}atients were separated into two groups according to {BFP} beneficiary status: {BFP} (exposed) or non-{BFP} (not exposed). {T}reatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. {P}earson's chi(2) test and {ANOVA} were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the {BFP} using a logit model. {W}e used multinomial regression models to evaluate the effect of the {BFP} on tuberculosis treatment outcomes. {F}indings 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the {BFP} and 1043 (84%) were not. {A}fter 6 months of treatment, 912 (87%) of 1043 patients in the non-{BFP} group and 173 (88%) of 196 patients in the {BFP} group were cured of tuberculosis, 103 (10%) patients in the non-{BFP} group and 17 (9%) patients in the {BFP} group had dropped out, and 25 (3%) patients in the non-{BFP} group and six (3%) patients in the {BFP} group had died. {T}hree (< 1%) of 1043 patients in the non-{BFP} group developed drug-resistant tuberculosis. {B}eing a {BFP} beneficiary had a positive effect for cure (average effect 0.076 [95% {CI} 0.037 to 0.11]) and a negative effect for dropout (-0.070 [-0.105 to 0.036]) and death (-0.002 [-0.021 to 0.017]). {I}nterpretation {BFP} alone had a direct effect on tuberculosis treatment outcome and could greatly contribute to the goals of the {WHO} {E}nd {TB} {S}trategy.},
  keywords = {{BRESIL}},
  booktitle = {},
  journal = {{L}ancet {G}lobal {H}ealth},
  volume = {7},
  numero = {2},
  pages = {{E}219--{E}226},
  ISSN = {2214-109{X}},
  year = {2019},
  DOI = {10.1016/s2214-109x(18)30478-9},
  URL = {https://www.documentation.ird.fr/hor/fdi:010074944},
}